Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
24,206.80
(
2.83%
)
Dow Jones
46,584.46
(
-0.18%
)
Brent Oil
91.94
(
-9.16%
)
Bitcoin
71,685.84
(
-0.42%
)
News Focus
News Focus
Post# of 257369
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122853
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Biopharm investor post# 54973

Sunday, 11/18/2007 9:23:32 PM

Sunday, November 18, 2007 9:23:32 PM

Post# of 257369
>Pfizer already has a wholly-owned subsidiary that markets generic versions of its own medicines: Greenstone.<

Greenstone is no Teva, however!

What PFE needs to do, IMO, is focus on financial engineering as described in my previous post. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today